NasdaqGS - Nasdaq Real Time Price USD

Masimo Corporation (MASI)

Compare

172.29

+2.35

+(1.38%)

At close: January 17 at 4:00:01 PM EST

172.29

0.00

(0.00%)

After hours: January 17 at 4:20:00 PM EST

Masimo Announces Select Preliminary 2024 Financial Results and 2025 Guidance

IRVINE, Calif., January 16, 2025--Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended December 28, 2024 and provided estimates for its full-year 2025 guidance.

Business Wire yesterday

MASI
+1.38%
What Does Masimo Corporation's (NASDAQ:MASI) Share Price Indicate?

While Masimo Corporation ( NASDAQ:MASI ) might not have the largest market cap around , it led the NASDAQGS gainers...

Simply Wall St. yesterday

MASI
+1.38%
Masimo to Present in the 43rd Annual J.P. Morgan Healthcare Conference

IRVINE, Calif., January 08, 2025--Masimo (NASDAQ: MASI) today announced that its management will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 10:30 a.m. Pacific time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation.

Business Wire 9 days ago

MASI
+1.38%
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories

Veracyte, Omnicell, Masimo and Abbott Laboratories are included in this Analyst Blog.

Zacks 28 days ago

OMCL

VCYT

MASI
+1.38%
4 Healthcare Technology Innovators to Invest in Before the New Year

Here, we have presented four healthcare technology stocks for stable portfolio gains in 2025: VCYT, OMCL, MASI and ABT.

Zacks 29 days ago

VCYT

OMCL

MASI
+1.38%
Those who invested in Masimo (NASDAQ:MASI) a year ago are up 50%

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But you can...

Simply Wall St. 30 days ago

MASI
+1.38%
3 Medical Instruments Industry Stocks to Buy on the GenAI Wave

MASI, PEN and VCYT from the Zacks Medical Instruments industry are worth buying based on genAI adoption, strategic developments and strong fundamentals. Yet, geopolitical complications and wage and supply issues mar their prospects.

Zacks last month

^GSPC

VCYT

MASI
+1.38%
Masimo lays off 75 employees in California

Under new leadership, the patient monitoring company is allocating resources to fewer projects as it focuses on market opportunities that address unmet needs, a spokesperson said.

MedTech Dive last month

MASI
+1.38%
Why Is Steris (STE) Up 0.9% Since Last Earnings Report?

Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks last month

STE

MASI
+1.38%
NARI Stock Likely to Gain Following Reimbursement Approval in Japan

Inari Medical announces reimbursement approval for ClotTriever Thrombectomy System in Japan and a new distribution partnership with Medikit.

Zacks last month

NARI

ANGO

MASI
+1.38%
The Zacks Analyst Blog Highlights MACOM Technology Solutions, Masimo, Leonardo DRS, Ingredion and Carpenter

MACOM Technology Solutions, Masimo, Leonardo DRS, Ingredion and Carpenter are included in this Analyst Blog.

Zacks last month

INGR

MASI
+1.38%
DRS
Buy 5 Mid-Cap Stocks Poised to Turn Into Large Caps in 2025

These mid-cap stocks have the potential to become large-caps in 2025. These are: MTSI, MASI, DRS, CRS, INGR.

Zacks last month

MTSI

INGR

DRS
Masimo to Present in the Piper Sandler 36th Annual Healthcare Conference

IRVINE, Calif., November 26, 2024--Masimo (NASDAQ: MASI) today announced that its management will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024 at 8:30 a.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation.

Business Wire last month

MASI
+1.38%
Masimo to Present in the Jefferies London Healthcare Conference

IRVINE, Calif., November 14, 2024--Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies London Healthcare Conference on Thursday, November 21, 2024 at 8:30 a.m. GMT. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation.

Business Wire 2 months ago

MASI
+1.38%
Masimo to Present in Stifel 2024 Healthcare Conference

IRVINE, Calif., November 13, 2024--Masimo (NASDAQ: MASI) today announced that its management will participate in the Stifel 2024 Healthcare Conference on Monday, November 18, 2024 at 11:30 a.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation.

Business Wire 2 months ago

MASI
+1.38%
Beat the Market Like Zacks: Sprouts Farmers Market, Kroger, Masimo in Focus

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

Zacks 2 months ago

^GSPC

KR

MASI
+1.38%
Is There An Opportunity With Masimo Corporation's (NASDAQ:MASI) 44% Undervaluation?

Key Insights The projected fair value for Masimo is US$302 based on 2 Stage Free Cash Flow to Equity Masimo's US$168...

Simply Wall St. 2 months ago

MASI
+1.38%
Masimo Third Quarter 2024 Earnings: EPS Misses Expectations

Masimo ( NASDAQ:MASI ) Third Quarter 2024 Results Key Financial Results Revenue: US$504.6m (up 5.4% from 3Q 2023). Net...

Simply Wall St. 2 months ago

MASI
+1.38%
Masimo's Q3 Earnings Rise Y/Y, Healthcare Demand Drives Growth

MAMO sees a 30.7% increase in non-GAAP operating income in Q3 2024. Healthcare segment revenues increase 11.5%, driving overall growth amid strategic shifts.

Zacks 2 months ago

MASI
+1.38%
MASI Stock Gains Following Q3 Earnings Beat, Gross Margin Expands

Masimo's third-quarter 2024 results continue to benefit from the strength in its Healthcare business.

Zacks 2 months ago

MASI
+1.38%
BSX

RMD
+1.12%

Performance Overview

Return	MASI	S&P 500
YTD	+2.19%	+1.52%
1-Year	+43.46%	+25.82%
3-Year	-26.08%	+28.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Masimo Corporation (MASI)

Masimo Announces Select Preliminary 2024 Financial Results and 2025 Guidance

What Does Masimo Corporation's (NASDAQ:MASI) Share Price Indicate?

Masimo to Present in the 43rd Annual J.P. Morgan Healthcare Conference

The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories

4 Healthcare Technology Innovators to Invest in Before the New Year

Those who invested in Masimo (NASDAQ:MASI) a year ago are up 50%

3 Medical Instruments Industry Stocks to Buy on the GenAI Wave

Masimo lays off 75 employees in California

Why Is Steris (STE) Up 0.9% Since Last Earnings Report?

NARI Stock Likely to Gain Following Reimbursement Approval in Japan

The Zacks Analyst Blog Highlights MACOM Technology Solutions, Masimo, Leonardo DRS, Ingredion and Carpenter

Buy 5 Mid-Cap Stocks Poised to Turn Into Large Caps in 2025

Masimo to Present in the Piper Sandler 36th Annual Healthcare Conference

Masimo to Present in the Jefferies London Healthcare Conference

Masimo to Present in Stifel 2024 Healthcare Conference

Beat the Market Like Zacks: Sprouts Farmers Market, Kroger, Masimo in Focus

Is There An Opportunity With Masimo Corporation's (NASDAQ:MASI) 44% Undervaluation?

Masimo Third Quarter 2024 Earnings: EPS Misses Expectations

Masimo's Q3 Earnings Rise Y/Y, Healthcare Demand Drives Growth

MASI Stock Gains Following Q3 Earnings Beat, Gross Margin Expands

Performance Overview